Brown Brothers Harriman & Co’s CalciMedica CALC Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$317	Hold	308	–	–	﹤0.01%	1791
2026 Q1	$166	Hold	308	–	–	﹤0.01%	1778
2025 Q4	$2.03K	Hold	308	–	–	﹤0.01%	1722
2025 Q3	$930	Hold	308	–	–	﹤0.01%	1630
2025 Q2	$471	Hold	308	–	–	﹤0.01%	1513
2025 Q1	$588	Hold	308	–	–	﹤0.01%	1274
2024 Q4	$1.09K	Hold	308	–	–	﹤0.01%	1373
2024 Q3	$1.36K	Hold	308	–	–	﹤0.01%	1336
2024 Q2	$1.22K	Buy	+308	New	+$1.55K	﹤0.01%	1092

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Brown Brothers Harriman & Co's CALC Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its CalciMedica (CALC) position steady in Q2 2026 at 308 shares worth $317. The position accounts for ﹤0.01% of the portfolio, ranked #1791.

Brown Brothers Harriman & Co first reported a position in CALC in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.03K in Q4 2025. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

Brown Brothers Harriman & Co held 308 shares of CalciMedica worth $317 as of Q2 2026.
Brown Brothers Harriman & Co left its CalciMedica share count unchanged in Q2 2026.
CalciMedica made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1791 holding.
Brown Brothers Harriman & Co first reported a position in CalciMedica in Q2 2024 and has held it in 9 quarters since.
Brown Brothers Harriman & Co's CalciMedica position peaked at $2.03K in Q4 2025.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.